The term Live Microbial Product (LMP) or Live Biotherapeutic Product (LBP) refers to products containing whole, live microorganisms, such as bacteria or yeast with an intended therapeutic or preventive effect in humans, regardless of the route of administration (oral, topical, intravenous, etc.).
SynCo has over 10 years of specialist experience in working with Live Microbial Products, which involves amongst others the development of scalable and fully closed mono-septic production processes (full aseptic handling from fermentation till filling of the product, capable to be administered as parenteral). As a world leader in this field, we are able to offer both bulk drug substance (BDS) and drug product (DP) production (including lyophilization) in our facilities in Amsterdam. SynCo has experience in working with many different types of Live Microbial Products and helped its customers to create a robust and controlled process, which gives the ability to move products through the various clinical phases towards commercial launch.
If you are interested to learn more about SynCo’s services for Live Microbial Products experience, please do not hesitate to contact us.